Cargando…

Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report

Wilms’ tumor is the most common primary renal malignancy in children (80%) and the less common tumors include renal cell carcinoma, rhabdoid tumor, clear cell sarcoma, cellular congenital mesoblastic nephroma and medullary carcinoma, all of which originate from renal parenchyma. The tumors originati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hengyou, Tang, Daxing, Wu, Dehua, Tao, Chang, Chen, Guangjie, Ru, Wei, Zhu, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658110/
https://www.ncbi.nlm.nih.gov/pubmed/33209693
http://dx.doi.org/10.21037/tau-20-834
_version_ 1783608596309737472
author Wang, Hengyou
Tang, Daxing
Wu, Dehua
Tao, Chang
Chen, Guangjie
Ru, Wei
Zhu, Kun
author_facet Wang, Hengyou
Tang, Daxing
Wu, Dehua
Tao, Chang
Chen, Guangjie
Ru, Wei
Zhu, Kun
author_sort Wang, Hengyou
collection PubMed
description Wilms’ tumor is the most common primary renal malignancy in children (80%) and the less common tumors include renal cell carcinoma, rhabdoid tumor, clear cell sarcoma, cellular congenital mesoblastic nephroma and medullary carcinoma, all of which originate from renal parenchyma. The tumors originating from renal pelvis are rare. The immunohistochemistry (IHC) showed INI1 deletion with the WT1 positive which has not been reported as we know. A 3-year-old boy was admitted to hospital for vomiting. An ultrasonography examination revealed a mass in the right kidney, medium echo, as well as hydronephrosis with collecting system separation of 3.5 cm. The computed tomography and the magnetic resonance (MR) radical showed that the tumor occupied the right renal pelvis and extended into the ureter. A radical nephroureterectomy was accomplished through a transabdominal approach. The pathologic diagnosis was malignant renal tumor with INI1 deficiency which was atypical in morphology and immunophenotype, but according to immunophenotype renal rhabdomyoid tumor could not be excluded. The patient was treated with carboplatin, etoposide and cyclophosphamide chemotherapy for 6 months. Follow-up studies of the patient showed no indication of recurrence or metastasis 22 months after nephrectomy. The novel findings may expand the spectrum of pediatric renal tumors to include the special malignancy.
format Online
Article
Text
id pubmed-7658110
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76581102020-11-17 Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report Wang, Hengyou Tang, Daxing Wu, Dehua Tao, Chang Chen, Guangjie Ru, Wei Zhu, Kun Transl Androl Urol Case Report Wilms’ tumor is the most common primary renal malignancy in children (80%) and the less common tumors include renal cell carcinoma, rhabdoid tumor, clear cell sarcoma, cellular congenital mesoblastic nephroma and medullary carcinoma, all of which originate from renal parenchyma. The tumors originating from renal pelvis are rare. The immunohistochemistry (IHC) showed INI1 deletion with the WT1 positive which has not been reported as we know. A 3-year-old boy was admitted to hospital for vomiting. An ultrasonography examination revealed a mass in the right kidney, medium echo, as well as hydronephrosis with collecting system separation of 3.5 cm. The computed tomography and the magnetic resonance (MR) radical showed that the tumor occupied the right renal pelvis and extended into the ureter. A radical nephroureterectomy was accomplished through a transabdominal approach. The pathologic diagnosis was malignant renal tumor with INI1 deficiency which was atypical in morphology and immunophenotype, but according to immunophenotype renal rhabdomyoid tumor could not be excluded. The patient was treated with carboplatin, etoposide and cyclophosphamide chemotherapy for 6 months. Follow-up studies of the patient showed no indication of recurrence or metastasis 22 months after nephrectomy. The novel findings may expand the spectrum of pediatric renal tumors to include the special malignancy. AME Publishing Company 2020-10 /pmc/articles/PMC7658110/ /pubmed/33209693 http://dx.doi.org/10.21037/tau-20-834 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Case Report
Wang, Hengyou
Tang, Daxing
Wu, Dehua
Tao, Chang
Chen, Guangjie
Ru, Wei
Zhu, Kun
Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title_full Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title_fullStr Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title_full_unstemmed Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title_short Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report
title_sort renal malignant tumor with the loss of ini1 expression and wt1 positive in a 3-year-old boy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658110/
https://www.ncbi.nlm.nih.gov/pubmed/33209693
http://dx.doi.org/10.21037/tau-20-834
work_keys_str_mv AT wanghengyou renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT tangdaxing renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT wudehua renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT taochang renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT chenguangjie renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT ruwei renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport
AT zhukun renalmalignanttumorwiththelossofini1expressionandwt1positiveina3yearoldboyacasereport